Cargando…

Tracers for non-invasive radionuclide imaging of immune checkpoint expression in cancer

ABSTRACT: Immunotherapy with checkpoint inhibitors demonstrates impressive improvements in the treatment of several types of cancer. Unfortunately, not all patients respond to therapy while severe immune-related adverse effects are prevalent. Currently, patient stratification is based on immunothera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wierstra, Peter, Sandker, Gerwin, Aarntzen, Erik, Gotthardt, Martin, Adema, Gosse, Bussink, Johan, Raavé, René, Heskamp, Sandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834817/ https://www.ncbi.nlm.nih.gov/pubmed/31696402 http://dx.doi.org/10.1186/s41181-019-0078-z

Ejemplares similares

PD-L1 Antibody Pharmacokinetics and Tumor Targeting in Mouse Models for Infectious Diseases
por: Sandker, Gerwin G. W., et al.
Publicado: (2022)

Combining Targeted Radionuclide Therapy and Immune Checkpoint Inhibition for Cancer Treatment
por: Kleinendorst, Simone C., et al.
Publicado: (2022)

Characterization of Intrinsically Radiolabeled Poly(lactic-co-glycolic acid) Nanoparticles for ex Vivo Autologous Cell Labeling and in Vivo Tracking
por: Krekorian, Massis, et al.
Publicado: (2021)

Longitudinal evaluation of the biodistribution and cellular internalization of the bispecific CD3xTRP1 antibody in syngeneic mouse tumor models
por: Sandker, Gerwin Gerhard Wemke, et al.
Publicado: (2023)

Quantitative Imaging of Hypoxic CAIX-Positive Tumor Areas with Low Immune Cell Infiltration in Syngeneic Mouse Tumor Models
por: Boreel, Daan F., et al.
Publicado: (2023)

Novel VHH-Based Tracers with Variable Plasma Half-Lives for Imaging of CAIX-Expressing Hypoxic Tumor Cells
por: van Lith, Sanne A.M., et al.
Publicado: (2022)

Imaging the Rewired Metabolism in Lung Cancer in Relation to Immune Therapy
por: van Genugten, Evelien A. J., et al.
Publicado: (2022)

A novel bispecific antibody for EGFR-directed blockade of the PD-1/PD-L1 immune checkpoint
por: Koopmans, Iris, et al.
Publicado: (2018)

Imaging of Tumor Hypoxia With Radionuclide-Labeled Tracers for PET
por: Huang, Yuan, et al.
Publicado: (2021)

PSMA Ligands for Radionuclide Imaging and Therapy of Prostate Cancer: Clinical Status
por: Lütje, Susanne, et al.
Publicado: (2015)

Environmental radionuclides: tracers and timers of terrestrial processes
por: Froehlich, Klaus
Publicado: (2009)

Direct comparison of the in vitro and in vivo stability of DFO, DFO* and DFOcyclo* for (89)Zr-immunoPET
por: Raavé, René, et al.
Publicado: (2019)

Additional information on “Direct comparison of the in vitro and in vivo stability of DFO, DFO* and DFOcyclo* for (89)Zr-immunoPET”
por: Raavé, René, et al.
Publicado: (2019)

(89)Zr-Immuno-Positron Emission Tomography in Oncology: State-of-the-Art (89)Zr Radiochemistry
por: Heskamp, Sandra, et al.
Publicado: (2017)

Development and evaluation of nanobody tracers for noninvasive nuclear imaging of the immune-checkpoint TIGIT
por: Zeven, Katty, et al.
Publicado: (2023)

Structure-Driven Design of Radionuclide Tracers for Non-Invasive Imaging of uPAR and Targeted Radiotherapy. The Tale of a Synthetic Peptide Antagonist
por: Ploug, Michael
Publicado: (2013)

Immune Checkpoints, Inhibitors and Radionuclides in Prostate Cancer: Promising Combinatorial Therapy Approach
por: Kgatle, Mankgopo M., et al.
Publicado: (2021)

In Vivo PET Imaging of Monocytes Labeled with [(89)Zr]Zr-PLGA-NH(2) Nanoparticles in Tumor and Staphylococcus aureus Infection Models
por: Krekorian, Massis, et al.
Publicado: (2021)

Extensive preclinical evaluation of lutetium-177-labeled PSMA-specific tracers for prostate cancer radionuclide therapy
por: Ruigrok, Eline A. M., et al.
Publicado: (2020)

Imaging carbonic anhydrase IX as a method for monitoring hypoxia-related radioresistance in preclinical head and neck cancer models
por: Huizing, Fokko J., et al.
Publicado: (2021)

Multiscale imaging of therapeutic anti-PD-L1 antibody localization using molecularly defined imaging agents
por: Hagemans, Iris M., et al.
Publicado: (2022)

Correction to: Multiscale imaging of therapeutic anti-PD-L1 antibody localization using molecularly defined imaging agents Iris
por: Hagemans, Iris M., et al.
Publicado: (2022)

Quantitative Imaging of the Hypoxia-Related Marker CAIX in Head and Neck Squamous Cell Carcinoma Xenograft Models
por: Huizing, Fokko J., et al.
Publicado: (2018)

Determination of radionuclides and radiochemical impurities produced by in-house cyclotron irradiation and subsequent radiosynthesis of PET tracers
por: Ishiwata, Kiichi, et al.
Publicado: (2016)

Imaging of T-cells and their responses during anti-cancer immunotherapy
por: Krekorian, Massis, et al.
Publicado: (2019)

Elucidating the Influence of Tumor Presence on the Polymersome Circulation Time in Mice
por: de Kruijff, Robin M., et al.
Publicado: (2019)

Receptor-Targeted Photodynamic Therapy of Glucagon-Like Peptide 1 Receptor–Positive Lesions
por: Boss, Marti, et al.
Publicado: (2020)

Targeted Optical Imaging of the Glucagonlike Peptide 1 Receptor Using Exendin-4-IRDye 800CW
por: Boss, Marti, et al.
Publicado: (2020)

Radionuclide Imaging of Invasive Fungal Disease in Immunocompromised Hosts
por: Lawal, Ismaheel O., et al.
Publicado: (2021)

Enhanced Specific Activity by Multichelation of Exendin-3 Leads To Improved Image Quality and In Vivo Beta Cell Imaging
por: Joosten, Lieke, et al.
Publicado: (2017)

The other immuno-PET: Metabolic tracers in evaluation of immune responses to immune checkpoint inhibitor therapy for solid tumors
por: Levi, Jelena, et al.
Publicado: (2023)

Case Report: Imaging immune checkpoint inhibitor-induced yin-yang effects in the brain
por: Bol, K. F., et al.
Publicado: (2023)

THERANOSTICS: From Molecular Imaging Using Ga-68 Labeled Tracers and PET/CT to Personalized Radionuclide Therapy - The Bad Berka Experience
por: Baum, Richard P., et al.
Publicado: (2012)

Comparison of [(18)F]DOPA and [(68)Ga]DOTA-TOC as a PET imaging tracer before peptide receptor radionuclide therapy
por: Veenstra, Emile B., et al.
Publicado: (2022)

EANM recommendations based on systematic analysis of small animal radionuclide imaging in inflammatory musculoskeletal diseases
por: Aarntzen, Erik H. J. G., et al.
Publicado: (2021)

Tumor cell-intrinsic and tumor microenvironmental conditions co-determine signaling by the glycoimmune checkpoint receptor Siglec-7
por: van Houtum, Eline J. H., et al.
Publicado: (2023)

Evaluation of single domain antibodies as nuclear tracers for imaging of the immune checkpoint receptor human lymphocyte activation gene-3 in cancer
por: Lecocq, Q., et al.
Publicado: (2021)

Comparison of the Tissue Distribution of a Long-Circulating Glucagon-like Peptide-1 Agonist Determined by Positron Emission Tomography and Quantitative Whole-Body Autoradiography
por: Fernandes, Eduardo Felipe Alves, et al.
Publicado: (2022)

Synergism of Checkpoint Inhibitors and Peptide Receptor Radionuclide Therapy in the Treatment of Pituitary Carcinoma
por: Lin, Andrew L, et al.
Publicado: (2021)

CAIX-targeting radiotracers for hypoxia imaging in head and neck cancer models
por: Huizing, Fokko J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7ts4cu9kkpgodrgvlnc0u55ij3